{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:26:41Z","timestamp":1792099601533,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00403-020-02148-0","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T05:02:53Z","timestamp":1603774973000},"page":"669-677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"313","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8700-480X","authenticated-orcid":false,"given":"Sherief R.","family":"Janmohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran C.","family":"Gwillim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3686-7805","authenticated-orcid":false,"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"issue":"2","key":"2148_CR1","first-page":"173","volume":"98","author":"C Zeidler","year":"2018","unstructured":"Zeidler C, Tsianakas A, Pereira M, Stander H, Yosipovitch G, Stander S (2018) Chronic prurigo of nodular type: a review. ActaDermatoVenereol 98(2):173\u2013179","journal-title":"ActaDermatoVenereol"},{"issue":"4","key":"2148_CR2","first-page":"291","volume":"87","author":"S Stander","year":"2007","unstructured":"Stander S, Weisshaar E, Mettang T et al (2007) Clinical classification of itch: a position paper of the International Forum for the Study of Itch. ActaDermatoVenereol 87(4):291\u2013294","journal-title":"ActaDermatoVenereol"},{"issue":"7","key":"2148_CR3","first-page":"1059","volume":"32","author":"MP Pereira","year":"2018","unstructured":"Pereira MP, Steinke S, Zeidler C et al (2018) European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J EurAcadDermatolVenereol\u202f: JEADV 32(7):1059\u20131065","journal-title":"J EurAcadDermatolVenereol : JEADV"},{"issue":"2","key":"2148_CR4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jaad.2019.07.022","volume":"82","author":"HF Stander","year":"2020","unstructured":"Stander HF, Elmariah S, Zeidler C, Spellman M, Stander S (2020) Diagnostic and treatment algorithm for chronic nodular prurigo. J Am AcadDermatol 82(2):460\u2013468","journal-title":"J Am AcadDermatol"},{"issue":"9859","key":"2148_CR5","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2163\u20132196","journal-title":"Lancet"},{"issue":"6","key":"2148_CR6","first-page":"681","volume":"17","author":"JI Silverberg","year":"2016","unstructured":"Silverberg JI, Hinami K, Trick WE, Cella D (2016) Itch in the general internal medicine setting: a cross-sectional study of prevalence and quality-of-life effects. Am J ClinDermatol 17(6):681\u2013690","journal-title":"Am J ClinDermatol"},{"issue":"3","key":"2148_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","volume":"121","author":"JI Silverberg","year":"2018","unstructured":"Silverberg JI, Gelfand JM, Margolis DJ et al (2018) Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Annal Allergy Asthma Immunol 121(3):340\u2013347","journal-title":"Annal Allergy Asthma Immunol"},{"issue":"4","key":"2148_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1398-9995.2008.01853.x","volume":"64","author":"M Maurer","year":"2009","unstructured":"Maurer M, Ortonne JP, Zuberbier T (2009) Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy 64(4):581\u2013588","journal-title":"Allergy"},{"issue":"3","key":"2148_CR9","first-page":"397","volume":"6","author":"VM Lim","year":"2016","unstructured":"Lim VM, Maranda EL, Patel V, Simmons BJ, Jimenez JJ (2016) A review of the efficacy of thalidomide and lenalidomide in the treatment of refractory prurigonodularis. DermatolTher 6(3):397\u2013411","journal-title":"DermatolTher"},{"key":"2148_CR10","doi-asserted-by":"publisher","unstructured":"Mishra SI, Scherer RW, Geigle PM et al (2012) Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev. 2012(8):CD007566. https:\/\/doi.org\/10.1002\/14651858.CD007566.pub2","DOI":"10.1002\/14651858.CD007566.pub2"},{"issue":"5","key":"2148_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/pai.12905","volume":"29","author":"HM Kansen","year":"2018","unstructured":"Kansen HM, Le TM, Meijer Y et al (2018) The impact of oral food challenges for food allergy on quality of life: a systematic review. Pediatr Allergy Immunol 29(5):527\u2013537","journal-title":"Pediatr Allergy Immunol"},{"key":"2148_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13643-015-0041-3","volume":"4","author":"CJ Apfelbacher","year":"2015","unstructured":"Apfelbacher CJ, Heinl D, Prinsen CA et al (2015) Measurement properties of adult quality-of-life measurement instruments for eczema: protocol for a systematic review. Syst Rev 4:48","journal-title":"Syst Rev"},{"issue":"6","key":"2148_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/ans.15097","volume":"89","author":"I Aristokleous","year":"2019","unstructured":"Aristokleous I, Saddiq M (2019) Quality of life after oncoplastic breast-conserving surgery: a systematic review. ANZ J Surg 89(6):639\u2013646","journal-title":"ANZ J Surg"},{"issue":"5","key":"2148_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jaad.2016.07.016","volume":"75","author":"R Kantor","year":"2016","unstructured":"Kantor R, Dalal P, Cella D, Silverberg JI (2016) Research letter Impact of pruritus on quality of life-a systematic review. J Am AcadDermatol 75(5):885-886 e884","journal-title":"J Am AcadDermatol"},{"key":"2148_CR15","unstructured":"Wells GA, Shea B, O\u2019Connell D et al (2014) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp Accessed 6 Jun 2020"},{"issue":"1","key":"2148_CR16","doi-asserted-by":"publisher","first-page":"e0147601","DOI":"10.1371\/journal.pone.0147601","volume":"11","author":"PA Modesti","year":"2016","unstructured":"Modesti PA, Reboldi G, Cappuccio FP et al (2016) Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS ONE 11(1):e0147601","journal-title":"PLoS ONE"},{"key":"2148_CR17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"key":"2148_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14:135","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2148_CR19","first-page":"157","volume":"33","author":"E Brenaut","year":"2019","unstructured":"Brenaut E, Halvorsen JA, Dalgard FJ et al (2019) The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries. J EurAcadDermatolVenereol JEADV 33(1):157\u2013162","journal-title":"J EurAcadDermatolVenereol JEADV"},{"issue":"1","key":"2148_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaad.2020.03.049","volume":"83","author":"A Chiricozzi","year":"2020","unstructured":"Chiricozzi A, Maurelli M, Gori N et al (2020) Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo. J Am AcadDermatol 83(1):39\u201345","journal-title":"J Am AcadDermatol"},{"issue":"5","key":"2148_CR21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/idoj.IDOJ_324_17","volume":"9","author":"L Dhawan","year":"2018","unstructured":"Dhawan L, Singh SM, Avasthi A, Kumaran MS, Narang T (2018) The prevalence of psychiatric comorbidity in patients with prurigonodularis. Indian Dermatol Online J 9(5):318\u2013321","journal-title":"Indian Dermatol Online J"},{"key":"2148_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2019.1659479","volume":"2","author":"S Ferrucci","year":"2019","unstructured":"Ferrucci S, Tavecchio S, Berti E, Angileri L (2019) Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy. J Dermatol Treat 2:1\u20132. https:\/\/doi.org\/10.1080\/09546634.2019.1659479","journal-title":"J Dermatol Treat"},{"key":"2148_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajp.2015.07.010","volume":"17","author":"D Konda","year":"2015","unstructured":"Konda D, Chandrashekar L, Rajappa M, Kattimani S, Thappa DM, Ananthanarayanan PH (2015) Serotonin and interleukin-6: association with pruritus severity, sleep quality and depression severity in prurigonodularis. Asian J Psychiatr 17:24\u201328","journal-title":"Asian J Psychiatr"},{"issue":"5","key":"2148_CR24","first-page":"525","volume":"60","author":"CC Oh","year":"2015","unstructured":"Oh CC, Li H, Lee W, Tey HL (2015) Biopsychosocial factors associated with prurigonodularis in endogenous eczema. Indian J Dermatol 60(5):525","journal-title":"Indian J Dermatol"},{"issue":"10","key":"2148_CR25","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1111\/jdv.16309","volume":"34","author":"MP Pereira","year":"2020","unstructured":"Pereira MP, Hoffmann V, Weisshaar E et al (2020) Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study. J Eur Acad Dermatol Venereol 34(10):2373\u20132383","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2148_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000355671","volume":"227","author":"D Siepmann","year":"2013","unstructured":"Siepmann D, Lotts T, Blome C et al (2013) Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigonodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial. Dermatology 227(4):353\u2013360","journal-title":"Dermatology"},{"issue":"6","key":"2148_CR27","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/bjd.12267","volume":"168","author":"S Stander","year":"2013","unstructured":"Stander S, Stumpf A, Osada N, Wilp S, Chatzigeorgakidis E, Pfleiderer B (2013) Gender differences in chronic pruritus: women present different morbidity, more scratch lesions and higher burden. Br J Dermatol 168(6):1273\u20131280","journal-title":"Br J Dermatol"},{"issue":"8","key":"2148_CR28","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1056\/NEJMoa1908316","volume":"382","author":"S Stander","year":"2020","unstructured":"Stander S, Yosipovitch G, Legat FJ et al (2020) Trial of nemolizumab in moderate-to-severe prurigonodularis. N Engl J Med 382(8):706\u2013716","journal-title":"N Engl J Med"},{"issue":"3","key":"2148_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jaad.2018.04.044","volume":"79","author":"S Steinke","year":"2018","unstructured":"Steinke S, Zeidler C, Riepe C et al (2018) Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am AcadDermatol 79(3):457-463 e455","journal-title":"J Am AcadDermatol"},{"issue":"8","key":"2148_CR30","first-page":"adv00119","volume":"100","author":"T Todberg","year":"2020","unstructured":"Todberg T, Zachariae C, Skov L (2020) Treatment and burden of disease in a cohort of patients with prurigonodularis: a survey-based study. ActaDermVenereol 100(8):adv00119","journal-title":"ActaDermVenereol"},{"issue":"4","key":"2148_CR31","first-page":"379","volume":"99","author":"A Tsianakas","year":"2019","unstructured":"Tsianakas A, Zeidler C, Riepe C et al (2019) Aprepitant in anti-histamine-refractory chronic nodular prurigo: a multicentre, randomized, double-blind, placebo-controlled, cross-over, phase-II trial (APREPRU). ActaDermatoVenereol 99(4):379\u2013385","journal-title":"ActaDermatoVenereol"},{"issue":"3","key":"2148_CR32","first-page":"210","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI)\u2013a simple practical measure for routine clinical use. ClinExpDermatol 19(3):210\u2013216","journal-title":"ClinExpDermatol"},{"issue":"4","key":"2148_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","volume":"125","author":"Y Hongbo","year":"2005","unstructured":"Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY (2005) Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol 125(4):659\u2013664","journal-title":"J Invest Dermatol"},{"issue":"4","key":"2148_CR34","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ard.37.4.378","volume":"37","author":"WW Downie","year":"1978","unstructured":"Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA (1978) Studies with pain rating scales. Ann Rheum Dis 37(4):378\u2013381","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2148_CR35","first-page":"502","volume":"92","author":"NQ Phan","year":"2012","unstructured":"Phan NQ, Blome C, Fritz F et al (2012) Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. ActaDermatoVenereol 92(5):502\u2013507","journal-title":"ActaDermatoVenereol"},{"issue":"2","key":"2148_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jaad.2008.04.006","volume":"59","author":"NS Desai","year":"2008","unstructured":"Desai NS, Poindexter GB, Monthrope YM, Bendeck SE, Swerlick RA, Chen SC (2008) A pilot quality-of-life instrument for pruritus. J Am AcadDermatol 59(2):234\u2013244","journal-title":"J Am AcadDermatol"},{"issue":"3","key":"2148_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"G EuroQol","year":"1990","unstructured":"EuroQol G (1990) EuroQol\u2013a new facility for the measurement of health-related quality of life. Health Policy 16(3):199\u2013208","journal-title":"Health Policy"},{"issue":"1","key":"2148_CR38","first-page":"101","volume":"158","author":"AW Evers","year":"2008","unstructured":"Evers AW, Duller P, van de Kerkhof PC et al (2008) The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol 158(1):101\u2013108","journal-title":"Br J Dermatol"},{"issue":"7","key":"2148_CR39","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1365-4632.2011.05383.x","volume":"51","author":"F Al-Qarqaz","year":"2012","unstructured":"Al-Qarqaz F, Al-Aboosi M, Al-shiyab D, Al DZ (2012) Using cold air for reducing needle-injection pain. Int J Dermatol 51(7):848\u2013852","journal-title":"Int J Dermatol"},{"issue":"S3","key":"2148_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/ddg.13795","volume":"17","author":"C Zeidler","year":"2019","unstructured":"Zeidler C, Stander S (2019) Kurzfragebogen zur Lebensqualit\u00e4t bei chronischem Pruritus: ein neues Instrument zur Nutzung in der Praxis. J Dtsch Dermatol Ges 17(S3):64\u201379","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"2148_CR41","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.jaci.2007.08.011","volume":"120","author":"J Schmitt","year":"2007","unstructured":"Schmitt J, Langan S, Williams HC, European D-E (2007) What are the best outcome measurements for atopic eczema? A systematic review. J Allergy ClinImmunol 120(6):1389\u20131398","journal-title":"J Allergy ClinImmunol"},{"issue":"5","key":"2148_CR42","first-page":"509","volume":"93","author":"S Stander","year":"2013","unstructured":"Stander S, Augustin M, Reich A et al (2013) Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. ActaDermatoVenereol 93(5):509\u2013514","journal-title":"ActaDermatoVenereol"},{"issue":"10","key":"2148_CR43","first-page":"2090","volume":"139","author":"JI Silverberg","year":"2019","unstructured":"Silverberg JI, Gelfand JM, Margolis DJ et al (2019) Validation and interpretation of short form 12 and comparison with dermatology life quality index in atopic dermatitis in adults. J InvestigDermatol 139(10):2090-2097 e2093","journal-title":"J InvestigDermatol"},{"issue":"5","key":"2148_CR44","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/bjd.17243","volume":"180","author":"KR Patel","year":"2019","unstructured":"Patel KR, Singam V, Vakharia PP et al (2019) Measurement properties of three assessments of burden used in atopic dermatitis in adults. Br J Dermatol 180(5):1083\u20131089","journal-title":"Br J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02148-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02148-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02148-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:28:02Z","timestamp":1669310882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02148-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2148"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02148-0","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest:"}},{"value":"Upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}}]}}